✦ LIBER ✦

Defining targets of modulation of human tumor cell response to cisplatin

✍ Scribed by Giovanni Luca Beretta; Laura Gatti; Elisabetta Corna; Nives Carenini; Franco Zunino; Paola Perego

Book ID: 108175085
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 764 KB
Volume: 102
Category: Article
ISSN: 0162-0134
DOI: 10.1016/j.jinorgbio.2008.01.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor responsiveness of squamous cell ca

Tumor responsiveness of squamous cell carcinoma to cisplatin

✍ Charles M. Stiernberg; Klara Valyi-Nagy; Price E. Hale; Francis B. Quinn; Byron 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

IN VITRO MODULATION OF CISPLATIN-INDUCED

IN VITRO MODULATION OF CISPLATIN-INDUCED TUMOR CELL APOPTOSIS BY INTEGRINS

✍ REY, Fabienne; BOUVIER, Martine; CAUSSANEL, Véronique; TABONE, Eric 📂 Article 📅 1996 🏛 Portland Press 🌐 English ⚖ 158 KB

A modified human ELISPOT assay to detect

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets

✍ Anatoli Malyguine; Susan L Strobl; Kimberly A Shafer-Weaver; Tracy Ulderich; Ang 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 508 KB

A p53-dominant transcriptional response

A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embyronal carcinoma

✍ Kerley-Hamilton, Joanna S; Pike, Aimee M; Li, Na; DiRenzo, James; Spinella, Mich 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 488 KB

Enhancement of tumor cell susceptibility

Enhancement of tumor cell susceptibility to tumor-infiltrating lymphocytes by cisplatin

✍ Kohei Noguchi; Hiroshi Tanimura; Hiroki Yamaue; Makoto Iwahashi; Takuya Tsunoda; 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 686 KB

Modulation of target cell susceptibility

Modulation of target cell susceptibility to human natural killer cells by interferon

✍ M. Moore; Wendy J. White; M. R. Potter 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 693 KB

## Abstract The spontaneous cytolytic activity of human peripheral blood lymphocytes in a short‐term ^51^chromium release assay was markedly enhanced by pretreatment with partially purified “Namalva” lymphoblastoid (type I)interferon (IF), provided that the target cells, five lymphoblastoid cell li